Hanmi Exports Drug Candidate Material Technology to MSD

SEOUL, Aug. 4 (Korea Bizwire) — Hanmi Pharmaceutical said Tuesday that it has exported technology for a liver treatment drug material to leading global drugmaker Merck Sharp & Dohme (MSD). The deal is for the efinopegdutide (HM12525A) candidate material that has potential to be used on people with nonalcoholic steatohepatitis (NASH) conditions, a kind of [...]